论文部分内容阅读
业已证实,90%急性心肌梗塞患者的冠状动脉(冠脉)内有血栓形成,冠脉内新鲜血栓是导致透壁性心肌梗塞最常见原因。上述的研究成果,为急性心肌梗塞时应用溶血栓疗法奠定了理论根据。及时应用溶血栓剂不仅可溶解新鲜血栓,使已经闭塞的冠脉再通和/或再灌注,从而可以挽救缺血和濒死的心肌,缩小梗塞面积,改善心功能及降低病死率。此外,通过纤溶系统活化机理,激活溶酶原成为纤溶酶,后者使纤
It has been demonstrated that thrombus formation in the coronary arteries (coronary arteries) in 90% of patients with acute myocardial infarction and fresh coronary thrombosis are the most common causes of transmural myocardial infarction. The above research results, the theoretical basis for the application of thrombolytic therapy for acute myocardial infarction. Timely application of thrombolytic agents can not only dissolve fresh thrombus, recanalization of the already closed coronary artery and / or reperfusion, which can save ischemic and dying myocardium, reduce infarct size, improve cardiac function and reduce mortality. In addition, through the fibrinolytic system activation mechanism, activation of plasminogen becomes plasmin, which makes fiber